tDCS Effect on Psychotic Symptoms in Dementia With Lewy Bodies (DLB), and Impacts on Caregiver Burden
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: active-tDCS, Sham-tDCS.
- Кому может быть актуально
- Состояния в реестре: Lewy Body Dementia, Lewy Body Dementia With Behavioral Disturbance, Burden, Caregiver, Lewy Body Disease. Базовые параметры: от 60 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Monaco
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Обзор
The goal of this pilot prospective study is to evaluate the effect of tDCS on psychotic-like symptoms in patients with Lewy Body Dementia (LBD). The main questions it aims to answer are: * What is the effect of tDCS on neuropsychiatric symptoms, especially psychotic-like symptoms? * What is the impact of tDCS on caregiver burden? Researchers will compare active tDCS (2mA stimulation, anode on the left dorsolateral prefrontal cortex, cathode on the right fronto-orbital) to Sham tDCS (placebo stimulation, no intensity applied) to see if there is an effect on reducing psychotic-like symptoms and on caregiver burden. Participants will: * Undergo a stimulation phase consisting of 10 tDCS sessions of 20 minutes each, spread over 2 consecutive weeks (5 days with stimulation, 2 days without stimulation, 5 days with stimulation). * perform assessments at T0 (inclusion), T1 (at the end of the stimulation phase), and T2 (follow-up at 8 weeks post stimulation).
Вмешательства
- Устройство active-tDCS
2mA stimulation (anode on the left dorsolateral prefrontal cortex, cathode on the right fronto-orbital). 10 sessions of 20 minutes each, spread over 2 consecutive weeks (5 days with stimulation, 2 days without stimulation, 5 days with stimulation). - Устройство Sham-tDCS
No intensity applied (anode on the left dorsolateral prefrontal cortex, cathode on the right fronto-orbital). 10 sessions of 20 minutes each, spread over 2 consecutive weeks (5 days with stimulation, 2 days without stimulation, 5 days with stimulation).
Первичные конечные точки
- Change from Baseline in the composite score named "psychotic factor" at T1 [Срок оценки: Baseline, Week 2]
- Change from Baseline in the composite score named "psychotic factor" at T2 [Срок оценки: Baseline, Week 10]
Вторичные конечные точки (12)
- Change from Baseline in the Neuropsychiatric Inventory (NPI) total score [Срок оценки: Baseline, Week 2, Week 10]
- Change from Baseline in the Neuropsychiatric Inventory (NPI) subscores [Срок оценки: Baseline, Week 2, Week 10]
- Change from Baseline in the Zarit scale score [Срок оценки: Baseline, Week 2, Week 10]
- Change from Baseline in the Trail Making Test (TMT) A&B performances [Срок оценки: Baseline, Week 2, Week 10]
- Change from Baseline in the Quality of life questionnaire (Qol) [Срок оценки: Baseline, Week 2, Week 10]
- Change from Baseline in the Mayo Clinic fluctuations scales score [Срок оценки: Baseline, Week 2, Week 10]
- Change from Baseline in the percentage of errors during an "antisaccades" paradigm [Срок оценки: Baseline, Week 2, Week 10]
- Change from Baseline in the saccades latency (in ms) during an "antisaccades" paradigm [Срок оценки: Baseline, Week 2, Week 10]
- Change from Baseline in the mean variation of latency times (in ms) during voluntary saccades [Срок оценки: Baseline, Week 2, Week 10]
- Change from Baseline in the frequency of square waves-jerks during horizontal eye movements paradigm [Срок оценки: Baseline, Week 2, Week 10]
- Change from Baseline in the frequency of fixations impairments during eye movements paradigm [Срок оценки: Baseline, Week 2, Week 10]
- Change from Baseline in the saccades main velocity during oculomotor paradigms [Срок оценки: Baseline, Week 2, Week 10]
Критерии участия
Критерии включения
- Male or Female, aged over 60,
- Diagnosed with a neurodegenerative pathology of the DLB type, at a moderate stage, according to the McKeith and al. (2017) criteria
- No change in antiparkinsonian or psychotropic medications, or cholinesterase inhibitors, for a period of one month prior to inclusion,
- Mini Mental State Examination (MMSE) > 15,
- Composite score called "psychotic factor" (corresponding to the sum of the psychotic-type symptoms sub-scores from the NPI \[12\]) greater than 0,
- Presence of a family caregiver,
- Sufficient written and oral expression in French,
- Written informed consent signed by the patient and his/her family caregiver
Критерии исключения
- History of alcoholism, drug addiction or neurological diseases such as brain trauma, epilepsy, encephalitis, intracranial normal-pressure hydrocephalus, etc. which may lead to cognitive impairment,
- Concomitant major psychiatric illness,
- Significant physical illness or comorbidities
- History of moderate to severe visual impairment secondary to glaucoma, cataract or macular degeneration,
- Patient under guardianship or curators
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Распределение
- Рандомизированное
- Модель
- Параллельные группы
- Маскирование
- Четверное слепое
- Основная цель
- Лечение
Центры проведения
Monaco · 1 центр
- Clinical Research Unit-Memory Clinic / Centre de Gérontologie Clinique Rainier III / Princ — Monaco
Идентификаторы
NCT: NCT06785948 · MCL-tDCS